2021
DOI: 10.1101/2021.09.03.458464
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Machine Learning prediction of cardiac resynchronisation therapy response from combination of clinical and model-driven data

Abstract: Background: Up to 30%-50% of chronic heart failure patients who underwent cardiac resynchronization therapy (CRT) do not respond to the treatment. Therefore, patient stratification for CRT and optimization of CRT device settings remain a challenge. Objective: The main goal of our study is to develop a predictive model of CRT outcome using a combination of clinical data recorded in patients before CRT and simulations of the response to biventricular (BiV) pacing in personalized computational models of the cardi… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 61 publications
0
1
0
Order By: Relevance
“…Sophisticated virtual heart simulations incorporating both MRI and PET data, then using ML to synthesize imaging and clinical data for SCD prediction, have been shown to outperform existing risk models ( 122 ). This approach is not specific to VA or SCD outcomes, and it has also been used to predict improvement in EF after cardiac resynchronization therapy ( 140 ). Because of the sheer volume of data available to the clinician from the electronic medical record and conglomerate imaging, it seems increasingly likely that ML will play a central role in the fusion of data of different sources and risk modeling ( 123 , 141 – 143 ).…”
Section: The Emerging Role Of Machine Learning and Artificial Intelli...mentioning
confidence: 99%
“…Sophisticated virtual heart simulations incorporating both MRI and PET data, then using ML to synthesize imaging and clinical data for SCD prediction, have been shown to outperform existing risk models ( 122 ). This approach is not specific to VA or SCD outcomes, and it has also been used to predict improvement in EF after cardiac resynchronization therapy ( 140 ). Because of the sheer volume of data available to the clinician from the electronic medical record and conglomerate imaging, it seems increasingly likely that ML will play a central role in the fusion of data of different sources and risk modeling ( 123 , 141 – 143 ).…”
Section: The Emerging Role Of Machine Learning and Artificial Intelli...mentioning
confidence: 99%